Getting a Read on Cancer Cancer patients are increasingly receiving treatments guided by the molecular characteristics of their cancer cells. But patients may have unequal access to testing and targeted therapies. by Kate Yandell Reinforcements for Cancer Research Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities. by Marci A. Landsmann Does Medicaid Expansion Have an Impact? Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients. by Marci A. Landsmann Achieving Health Equality National Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities. by Marci A. Landsmann The Roots of Rural Health Disparities New research shows that rural cancer patients have the same health outcomes as urban cancer patients so long as they are involved in a clinical trial. by Cheryl Platzman Weinstock A New Guideline for Cervical Cancer Screening Physicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening. by Anna Azvolinsky Policy Matters Putting an End to Cancer Health Disparities Cancer has a disproportionate impact on disadvantaged and minority groups. The AACR 2020 by 2020 initiative is a step toward closing the gap. by Michael A. Caligiuri, MD Forward Look Opening Clinical Trials to HIV-Positive Cancer Patients Including patients with HIV is part of a larger effort to broaden cancer clinical trial eligibility. by Andy Kopsa Forward Look Lung Cancer Biology Differs by Race, Study Shows Research findings could help improve personalized treatments for lung cancer patients. by Stephen Ornes Omitting Obesity Many cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research. by Cici Zhang next Cancer Talk Considering the Term “Cancer Survivor” A study investigates how people who have been diagnosed with cancer feel about being called survivors. by Jen Tota McGivney Making Clinical Trials More Inclusive Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment. by Ashley P. Taylor What Do Clinical Trial Endpoints Really Measure? A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life. by Jon Kelvey Shingles Risk Increased for Cancer Patients A new vaccine is safe for cancer patients but hard to find. by Nancy Averett More Posts